Disease associations in 250 patients with temporal (giant cell) arteritis;Maladie de horton: Associations morbides chez 250 malades

Presse Medicale

Volumn 33, Issue 19 I, 2004, Pages 1304-1312

  Liozon, Éric ^a,b   Loustaud Ratti, V ^a   Soria, P ^a   Bezanahary, H ^a   Fauchais, A L ^a   Nadalon, S ^a   Rhaiem, K ^a   Ly, K ^a   Vidal, E ^a  

^a Hôpital Universitaire Médecine Vasculaire   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD DISEASE; CANCER; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HASHIMOTO DISEASE; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MYASTHENIA; NECROTIZING ARTERITIS; NEPHROTIC SYNDROME; OSTEOLYSIS; POLYNEUROPATHY; PREVALENCE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SJOEGREN SYNDROME; TEMPORAL ARTERITIS; THROMBOCYTHEMIA;

EID: 9144243578     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98914-2     Document Type: Article

References (81)

1. Hunder GG, Lie JT, Goronzy JJ, Weyand CM. Pathogenesis of giant cell arteritis. Arthritis Rheum 1993; 36: 757-61.
2. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994; 121: 484-91.
3. Barrier JH, Bignon JD, Soulillou JP, Grolleau J. Increased prevalence of HLA-DR4 in giant cell arteritis. N Engl J Med 1981; 305: 104-5.
4. Richardson JE, Gladman DD, Fam A, Keystone EC. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome. Arthritis Rheum 1987; 30: 1293-7.
5. Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994; 37: 514-20.
6. Machado EB, Gabriel SE, Beard CM, Michet CJ, O'Fallon WM, Ballard DJ. A population-based, case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 1989; 18; 836-41.
7. Duhaut P, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Ninet J et al. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective, case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes, Arthritis Rheum 1998; 41: 1960-5.
8. Haga HJ, Eide GE, Brun J, Johansen A, Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993; 20: 1335-9.
9. Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and giant cell arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996; 35: 1161-8.
10. Dasgupta B, Grundy E, Stainer E. Hypothyroidism in polymyalgia rheumatica and giant cell arteritis: lack of any association. BMJ 1990; 301: 96-7.
11. Barrier JH, Abram M, Brisseau JM, Planchon B, Grolleau JY. Autoimmune thyroid diseases, thyroid antibodies and giant cell arteritis: the supposed correlation appears fortuitous. J Rheumatol 1992; 19: 1733-4.
12. Duhaut P, Bornet H, Pinede L et al. Giant cell arteritis and thyroid dysfunction: a multicentre case-control study. BMJ 1999; 318: 434-5.
13. Godeau P, Lemaitre MO, Wechsler B, Guillevin L, Herson S. Association maladie de Horton et périartérite noueuse. Sem Hôp Paris 1984; 60: 30-4.
14. Vidal E, Liozon F, Rogues AM, Cransac M, Berdah JF, Liozon E. Concurrent temporal arteritis and Churg-Strauss syndrome. J Rheumatol 1992; 19: 1312-14.
15. Nishino H, Deremee R, Rubino FA, Parisi JE. Wegener's granulomatosis associated with vasculitis of the temporal artery: report of five cases, Mayo Clin Proc 1993; 68: 115-21.
16. Genereau T, Lortholary O, Pottier MA et al. Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. Arthritis Rheum 1999; 42: 2674-81.
17. Hamidou MA, Moreau A, Toquet C, EL Kouri D, De Faucal P, Grolleau JY. Temporal arteritis associated with necrotizing vasculitis. J Rheumatol 2003; 30: 2165-9.
18. Genereau T, Herson S. Les artérites temporales. Éléments du diagnostic différentiel de la maladie de Horton. Ann Med Interne 1993; 144: 198-211.
19. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elvebach LR. Temporal arteritis. A 25-year epidemioiogic, clinical and pathologic study. Ann Intern Med 1978; 88: 162-7.
20. Hunder GG, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-8.
21. Liozon E, Hermann FR, LY K, Jauberteau MO, Loustaud V, Soria P et al. Facteurs prédictifs de complications ischémiques irréversibles au cours de la maladie de Horton: étude prospective sur 178 patients. Rev Med Interne 2001; 22: 1-12.
22. Liozon E, Hermann F, Ly K et al. Risk factors for visual loss in giant cell (temporal) arteritis. A prospective study of 174 patients. Am J Med 2001; 111: 211-17.
23. Liozon E, Boutros-Toni F, LY K, Loustaud-Ratti V, Soria P, Vidal E. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course. J Rheumatol 2003; 30: 1272-6.
24. Bennet JM, Catovsky D, Daniel MT et al. Proposals fort the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-99.
25. Vitali C, Bombardieri S, Moutsopoulos HM et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of well-defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996; 55: 116-21.
26. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
27. Naschitz JE, Yeshurun D, Rosmer I. Rheumatic manifestations of occult cancer. Cancer 1995; 75: 2954-8.
28. Haugeberg G, Dovland H, Johnsen V. Increased frequency of malignancy found in patients with new-onset polymyalgic symptoms suggested to have polymyalgia rheumatica. Arthritis Rheum (Arthritis Care Res) 2002; 47: 346-8.
29. Castro M, Conn DL, Su D, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 1991; 18: 721-7.
30. George SW, Newman ED. Seronegative inflammatory arthritis in the myelodysplastic syndromes. Arthritis Rheum 1992; 21: 345-54.
31. Kohli M, Bennett RM. An association of polymyalgia rheumatica with myelodysplastic syndromes. J Rheumatol 1994; 21: 1357-9.
32. Hebbar M, Hebbar-Savean K, Fenaux P. Maladies systémiques au cours des syndromes myélodysplasiques. Rev Méd Interne 1995; 16: 897-904.
33. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42: 311-7.
34. Hulin C, Hachulla E, Michon-Pasturel U et al. Prévalence des anticorps anti-phospholipides dans la maladie de Horton et la pseudopolyarthrite rhizomélique. Rev Med interne 1999; 20: 659-63.
35. Duhaut P, Berruyer M, Pinede L et al. Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Goupe de recherche sur l'artérite à cellules géantes. Arthritis Rheum 1998; 41: 701-9.
36. Liozon F, Jauberteau-Marchan MO, Boutros-Toni F et al. Anticorps anti-cardiolipine et maladie de Horton. Ann Med Interne 1995; 146: 541-7.
37. Liozon E, Roblot P, Paire D et al. Anticardiolipin antibody levels predicts flares and relapses in patients with giant cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Rheumatology (Oxford) 2000; 39: 1089-94.
38. De Coninck P, Büschges B, Thouvenin T, Auxenfants E, Bouton Y, Plouvier B. Manifestations dysimmunitaires au cours de la maladie de Horton et de la pseudopolyarthrite rhizomélique, Presse Med 1989; 18: 1435.
39. Berthelot JM, Lamour A, Mottier D et al. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica. Ann Med Interne 1992; 143: 429-32.
40. Cats HA, Terwaert JW, Van Wijk R, Limburg PC, Kallenberg CG. Anti-neutrophil cytoplasmic antibodies in patients with giant cell arteritis and polymyalgia rheumatica. Adv Exp Med Biol 1993; 336: 363-6.
41. Baranger TA, Audrain MA, Castagne A, Barrier JH, Esnault VL. Absence of Anti-neutrophil cytoplasmic antibodies in patients with giant cell arteritis. J Rheumatol 1994; 21: 871-3.
42. Haugeberg G, Bie R, Johnsen V. Vasculitic changes in the temporal artery in polyarteritis nodosa. Scand J Rheumatol 1997; 26: 383-5.
43. Graham E. Survival in temporal arteritis. Trans Ophthal Soc UK 1980; 100: 108-10.
44. Andersson R, Malmvall BE, Bengtsson BA. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids. Acta Med Scand 1986; 220: 361-4.
45. Nordborg E, Bengtsson BA. Death rates and causes in 284 consecutive patients with giant cell arteritis confirmed by biopsy. Br Med J 1989; 299: 549-50.
46. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a danish county. A prospective investigation, 1982-1985. Arthritis Rheum 1987; 30: 294-9.
47. Mertens JCC, Willemsen G, Van Saase JLCM, Bolk JH, Dijkmans BAC. Polymyalgia rheumatica and temporal arteritis: a retrospective study of 111 patients. Clin Rheumatol 1995; 14: 650-5.
48. Hamrin B, Jonsson N, Hellsten S. "Polymyalgia arteritica". Further clinical and histopathological studies with a report of six autopsy cases. Ann Rheum Dis 1968; 27: 397-405.
49. Östberg G. Temporal arteritis in a large necropsy series, Ann Rheum Dis 1971; 30: 224-35.
50. Von Knorring J, Sommer T. Malignancy in association with polymyalgia rheumatica and temporal arteritis. Scand J Rheumatol 1974; 3: 129-35.
51. Hammoudeh M, Kahn MA. Cranial arteritis as the initial manifestation of malignant histiocytosis. J Rheumatol 1982; 9: 443-7.
52. Larregain-Fournier D, ADoue p, Arlet P, Le Tallec Y. Maladie de Norton et pseudo-polyarthrite rhizomélique associée àune leucémie lymphoïde chronique. Presse Med 1984; 13: 2210.
53. Hoag GN. Renal carcinoma and vasculitis: report of two cases. J Surg Oncol 1987; 35: 35-8.
54. Case records of the Massachusetts General Hospital. Case 23-1990. N Engl J Med 1990; 322: 1656-65.
55. Bensaïd P, Vaillant L, Machet L, De Muret A, Roquejoffre P, Lorette G. Maladie de Norton et syndrome myélodysplasique associés à des manifestations cutanées inhabituelles. Ann Dermatol Venereol 1992; 119: 217-20.
56. Lie JT. Simultaneous clinical manifestations of malignancy and giant cell temporal arteritis in a young woman. J Rheumatol 1995; 22: 367-9.
57. Speed CA, Haslock I. Polymyalgia rheumatica, temporal arteritis and malignancy. Postgrad Med J 1995; 71: 500-2.
58. Gonzalez-Gay MA, Blanco R, Gonzalez-Lopez MA. Simultaneous presentation of giant cell arteritis and chronic lymphocytic leukemia. J Rheumatol 1997; 24: 407-8.
59. Keung YK, Yung C, Wong JW, Shah F, Cobos E. Association of temporal arteritis, retinal vasculitis, and xanthomatosis with multiple myeloma: case report and literature review. Mayo Clin Proc 1998; 73: 657-60.
60. Solans R, Selva A, Matas L, Simeon CP, Bosch JA, Vilardell M. Paraneoplastic vasculitis in patients with solid tumors. Eur J Intern Med 1999; 10 (Suppl. 1): 560.
61. Hutson TE, Hoffman GS. Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis Care Res 2000; 13: 417-23.
62. Orbo A, Steffensen A. Endometrial cancer, vasculitis of the genital tract and occult temporal arteritis. Histopathology 2000; 38: 177-9.
63. Espinosa G, Font J, Munoz-Rodriguez FJ, Cervera R, Ingelmo M, Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol 2002; 21: 309-13.
64. Plouvier B, De Coninck P, Büschges-Seraphin B, Bouton Y, Thouvenin T, Auxenfants E. Relations entre maladie de Norton, pseudo-polyarthrite rhizomélique et cancer. Presse Med 1989; 18: 1977.
65. Schmidt J, Merlet V, Aublet-Cuvelier B, André M, Aumaitre O. Prévalence du cancer chez 75 patients porteurs d'une maladie de Norton et/ou d'une pseudopolyarthrite rhizomélique. Rev Med Interne 1999; 20 (Suppl 1): 85s.
66. Lesser R, Aledort D, Lie JT. Non-giant cell arteritis of the temporal artery presenting as the polymyalgia-temporal arteritis syndrome J Rheumatol 1995; 22: 2177-82.
67. Roth AM, Milsow L, Keltner JL. The ultimate diagnosis of patients undergoing temporal artery biopsy. Arch Ophthalmol 1984; 102: 901-3.
68. Chagnon JP, Brion N, Yeni P, Barge J, Isoul R, Carbon C. Récidive tardive d'une maladie de Norton avec syndrome sec. Sem Hôp París 1983; 59: 189-91.
69. Semble EL, Agudelo CA, Challa VR, Heise ER, Pisko EJ. Temporal arteritis in Sjögren's syndrome. Clin Exp Rheumatol 1985; 3: 345-7.
70. Ponge T, Alliaume C, Ponge A, Berthelot JM, Cottin S. Maladie de Norton et syndrome de Gougerot-Sjögren: association fortuite ou méconnue? Ann Med Interne 1988; 139: 227-30.
71. Meloni F, Nigro D, Transi MG et al. Norton's disease and Sjögren's syndrome. A case report. Clin Exp Rheumatol 1989; 7: 660-1.
72. Caselli RJ, Daube JR, Hunder GG, Whisnant JP. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology 1988; 38: 685-9.
73. Mac Gregor MA. Hyperthyroidism and giant cell arteritis. Br Med J 1974; 2: 483-4.
74. Nicholson GC, Gutteridge DH, Caroll WM, Amstrong BK. Autoimmune thyroid disease and giant cell arteritis: a review, case report and epidemiologic study. Aust NZ J Med 1984; 14: 487-90.
75. Bertola G, Torchio G, Boccia M, Meregalli M, Santangelo M. Temporal arteritis associated with hyperthyroidism and complicated by angina pectoris. A case report. Minerva Med 1996; 87: 105-8.
76. Marcussen N, Lund C. Combined sarcoidosis and disseminated visceral giant cell vasculitis. Pathol Res Pract 1989; 18: 235-30.
77. Procter PR, Lotz BP. Sarcoidosis in giant cell arteritis. Clin Exp Dermatol 1992; 17: 143-4.
78. Fernandes SR, Singsen BH, Hoffman GS. Sarcoidosis and systemic vasculitis. Semin Arthritis Rheum 2000; 30: 33-46.
79. Salvarani C, Hunder GG. Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis. Arthritis Rheum 1999; 42: 1259-66.
80. Monteagudo M, Vidal G, Andreu J et al. Giant cell (temporal) arteritis and secondary renal amyloidosis: report of 2 cases. J Rheumatol 1997; 24: 605-7.
81. Truong L, Kopelman RG, Williams GS, Pirani CS. Temporal arteritis and renal disease. Case report and review of the literature. Am J Med 1985; 78: 171-5.